These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27167388)

  • 1. Cytochrome P450 structure-function: insights from molecular dynamics simulations.
    Nair PC; McKinnon RA; Miners JO
    Drug Metab Rev; 2016 Aug; 48(3):434-52. PubMed ID: 27167388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
    Dong D; Wu B
    Drug Metab Rev; 2012 Feb; 44(1):1-17. PubMed ID: 22242930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational diversity and ligand tunnels of mammalian cytochrome P450s.
    Yu X; Cojocaru V; Wade RC
    Biotechnol Appl Biochem; 2013; 60(1):134-45. PubMed ID: 23587001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal Structure of Cytochrome P450 (CYP105P2) from Streptomyces peucetius and Its Conformational Changes in Response to Substrate Binding.
    Lee CW; Lee JH; Rimal H; Park H; Lee JH; Oh TJ
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of steroid binding and oxidation by the cytochrome P450 CYP109E1 from Bacillus megaterium.
    Jóźwik IK; Kiss FM; Gricman Ł; Abdulmughni A; Brill E; Zapp J; Pleiss J; Bernhardt R; Thunnissen AW
    FEBS J; 2016 Nov; 283(22):4128-4148. PubMed ID: 27686671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Your Crystal Structure Will Not Tell You about Enzyme Function.
    Pochapsky TC; Pochapsky SS
    Acc Chem Res; 2019 May; 52(5):1409-1418. PubMed ID: 31034199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into regioselective metabolism of mefenamic acid by cytochrome P450 BM3 mutants through crystallography, docking, molecular dynamics, and free energy calculations.
    Capoferri L; Leth R; ter Haar E; Mohanty AK; Grootenhuis PD; Vottero E; Commandeur JN; Vermeulen NP; Jørgensen FS; Olsen L; Geerke DP
    Proteins; 2016 Mar; 84(3):383-96. PubMed ID: 26757175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into understudied human cytochrome P450 enzymes.
    Machalz D; Pach S; Bermudez M; Bureik M; Wolber G
    Drug Discov Today; 2021 Oct; 26(10):2456-2464. PubMed ID: 34161845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand Access Channels in Cytochrome P450 Enzymes: A Review.
    Urban P; Lautier T; Pompon D; Truan G
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29848998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and function of cytochromes P450 2B: from mechanism-based inactivators to X-ray crystal structures and back.
    Halpert JR
    Drug Metab Dispos; 2011 Jul; 39(7):1113-21. PubMed ID: 21502194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Dynamics Simulations of a Cytochrome P450 from
    Faponle AS; Roy A; Adelegan AA; Gauld JW
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34204747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Conserved Allosteric Site on Drug-Metabolizing CYPs: A Systematic Computational Assessment.
    Fischer A; Smieško M
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of cytochrome P450 CYP119 ligand-dependent conformational dynamics by two-dimensional NMR and X-ray crystallography.
    Basudhar D; Madrona Y; Kandel S; Lampe JN; Nishida CR; de Montellano PR
    J Biol Chem; 2015 Apr; 290(16):10000-17. PubMed ID: 25670859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Species-Selectivity of Human, Mouse and Rat Cytochrome P450 1A and 2B Subfamily Enzymes using Molecular Modeling, Docking and Dynamics Simulations.
    Karthikeyan BS; Suvaithenamudhan S; Akbarsha MA; Parthasarathy S
    Cell Biochem Biophys; 2018 Jun; 76(1-2):91-110. PubMed ID: 28353142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics simulations of P450 BM3--examination of substrate-induced conformational change.
    Chang YT; Loew GH
    J Biomol Struct Dyn; 1999 Jun; 16(6):1189-203. PubMed ID: 10447203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying cytochrome p450 functional networks and their allosteric regulatory elements.
    Liu J; Tawa GJ; Wallqvist A
    PLoS One; 2013; 8(12):e81980. PubMed ID: 24312617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated structure- and ligand-based in silico approach to predict inhibition of cytochrome P450 2D6.
    Martiny VY; Carbonell P; Chevillard F; Moroy G; Nicot AB; Vayer P; Villoutreix BO; Miteva MA
    Bioinformatics; 2015 Dec; 31(24):3930-7. PubMed ID: 26315915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Dynamics Simulations to Investigate the Influences of Amino Acid Mutations on Protein Three-Dimensional Structures of Cytochrome P450 2D6.1, 2, 10, 14A, 51, and 62.
    Fukuyoshi S; Kometani M; Watanabe Y; Hiratsuka M; Yamaotsu N; Hirono S; Manabe N; Takahashi O; Oda A
    PLoS One; 2016; 11(4):e0152946. PubMed ID: 27046024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Allosterism" in the elementary steps of the cytochrome P450 reaction cycle.
    Yoon MY; Campbell AP; Atkins WM
    Drug Metab Rev; 2004 May; 36(2):219-30. PubMed ID: 15237852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in molecular modeling of human cytochrome P450 polymorphism.
    Martiny VY; Miteva MA
    J Mol Biol; 2013 Nov; 425(21):3978-92. PubMed ID: 23856621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.